CASIRIVIMAB vs CEFDINIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CASIRIVIMAB vs CEFDINIR: Safety Overview
| Metric | CASIRIVIMAB | CEFDINIR |
|---|---|---|
| Total FAERS Reports | 500 | 1,627 |
| Deaths Reported | 24 | 35 |
| Death Rate | 4.8% | 2.2% |
| Hospitalizations | 209 | 262 |
| Average Patient Age | 58.9 yrs | 37.8 yrs |
| % Female Patients | 52.4% | 65.6% |
| FDA Approval Date | N/A | Apr 6, 2007 |
| Manufacturer | N/A | Sandoz Inc |
| Route | N/A | ORAL |
| Marketing Status | N/A | Discontinued |